Quadripolar Leads for the Management of Heart Failure Patients in the Middle East

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 389 participants.

Also called NCT02195843

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking
Phase
Phase 4
Enrolled
  • 389 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02195843
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02195843. Randomized; no masking. Start 2014-08 (registry gives no type); primary completion 2016-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Quadripolar Leads for the Management of Heart Failure Patients in the Middle East
Acronym
QUADRA-ME
Condition
Heart Failure
Intervention (Other)
Electrical optimization by RVLV Conduction Time with VectSelect
Intervention (Other)
Anatomical optimization of device and leads
Intervention (Device)
Implanted device and lead (Cardiac Resynchronization Therapy Defibrillator (CRT-D) device and SJM Quadripolar lead system)
Lead sponsor
King Abdullah International Medical Research Center (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct02195843
Content hash
8a80dd2e4e7235e5410b6aadf64dec8c293a2fb715d699b9c770f35a7c90eb7c